Cancer
« Previous Entries Next Entries »
Monday, November 17th, 2008
Data from a new survey of 550 physicians and specialists across Europe indicate that 47% of physicians are not carrying out regular molecular monitoring for patients with Chronic Myeloid Leukaemia (CML).1 Results from the UK show that a quarter of physicians surveyed do not follow molecular monitoring recommendations; this may impact clinical decision making in […]
This entry was important to me:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Monday, November 17th, 2008
GE Healthcare, a unit of General Electric Company (NYSE:GE), announced that the Food and Drug Administration (FDA) has approved AdreView™ (Iobenguane I 123 Injection), a molecular imaging agent for the detection of rare neuroendocrine tumors in children and adults. AdreView provides high quality images that allow physicians to detect tumors, both at the time of […]
This entry was important to me:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Monday, November 17th, 2008
Serena M. Bordes, doctor of naturopathy, licensed acupuncturist and diplomate in acupuncture, has been recognized by Cambridge Who’s Who for excellence in the practice of naturopathy and Oriental medicine. Bordes, an esteemed V.I.P. member of Cambridge Who’s Who, is now organizing local seminars to enlighten community members about the many benefits of naturopathic treatment. [click […]
This entry was important to me:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Sunday, November 16th, 2008
AFP - While chemotherapy can remove breast cancer tumors, it fails to root out the stem cells that can revive the cancer, researchers said in a study published Tuesday. (Link)
This entry was important to me:
These icons link to social bookmarking sites where readers can share and discover new web pages.
This entry was important to me:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Sunday, November 16th, 2008
HealthDay - THURSDAY, Feb. 7 (HealthDay News) — An anti-cancer proteinthat's naturally produced and secreted by the body can make the differencebetween a common mole and deadly melanoma skin cancer, a new studysays. (Link)
This entry was important to me:
These icons link to social bookmarking sites where readers can share and discover new web pages.
This entry was important to me:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Saturday, November 15th, 2008
HealthDay - TUESDAY, June 10 (HealthDay News) — Costs for treating Medicarepatients with cancer increased substantially from 1991 to 2002,researchers report. (Link)
This entry was important to me:
These icons link to social bookmarking sites where readers can share and discover new web pages.
This entry was important to me:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Saturday, November 15th, 2008
HealthDay - WEDNESDAY, March 19 (HealthDay News) — Quality-of-life issuesshould be weighed carefully when prostate cancer patients are consideringthe thicket of treatment options available to them, new research suggests. (Link)
This entry was important to me:
These icons link to social bookmarking sites where readers can share and discover new web pages.
This entry was important to me:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Friday, November 14th, 2008
Researchers from Boston University School of Medicine have developed a new “clinicogenomic model” to accurately test for lung cancer. The model combines a specific gene expression for lung cancer as well as clinical risk factors. These findings currently appear on-line in the journal Cancer Prevention Research.Lung cancer is the leading cause of cancer death in […]
This entry was important to me:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Friday, November 14th, 2008
Admin wrote: Immutep S.A. announced today that the FDA, after review of the Investigational New Drug Application (IND), has allowed the administration of IMP321 in cancer patients in a Phase I trial conducted by Dr. William G. Hawkins at the Washington University School of Medicine in Saint Louis (MO). (Link)
This entry was important to me:
These icons […]
This entry was important to me:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Thursday, November 13th, 2008
In a landmark study, Medical College of Wisconsin researchers in Milwaukee report that drugs used to inhibit a specific fatty acid in rat brains with glioblastoma-like tumors not only reduced new blood vessel growth and tumor size dramatically, but also prolonged survival. The study is the featured cover story of the August, 2008 Journal of […]
This entry was important to me:
These icons link to social bookmarking sites where readers can share and discover new web pages.
« Previous Entries Next Entries »
Loading ...
